Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / *W EXP 12/17/202
-
Total 13F shares
-
8,698,230
-
Share change
-
+651,445
-
Total reported value
-
$8,150,297
-
Price per share
-
$0.94
-
Number of holders
-
22
-
Value change
-
+$712,708
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) as of Q4 2025
As of 31 Dec 2025,
Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,698,230 shares.
The largest 10 holders included
LMR Partners LLP, D. E. Shaw & Co., Inc., ARISTEIA CAPITAL, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., Lunate Capital Ltd, SOROS CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, Bleichroeder LP, and Sculptor Capital LP.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.